Global Multiple Sclerosis Cases Have Reached 3.1 Million
A new international study reports that global MS prevalence has increased by 54 percent over the past decade.
Updated on Sept. 22, 2026 in Stroke
Live Poll
Do you believe rising disease statistics more often reflect improved reporting than actual changes in health?
Approximately 3.1 million people worldwide are now living with multiple sclerosis, according to a comprehensive study covering 93 percent of the global population. Researchers found that cases have risen by 54 percent over the last ten years.
Why it matters
The reported rise in prevalence is attributed to improved data collection techniques, more sensitive diagnostic methods, and longer life expectancies for those diagnosed with the condition. These findings highlight a growing need for global healthcare resources to support a larger patient population.
The study utilized data from 133 countries to account for 3.1 million patients, of which 70 percent are women. Additionally, over 40,000 children and adolescents are currently living with the condition.
The players
MS International Federation
This is a global non-profit organization that coordinates research and advocacy efforts for individuals affected by multiple sclerosis.
The details
Researchers updated the MS International Federation's Atlas of MS by analyzing data across 133 countries and regions. The findings suggest that as medical practices evolve and life expectancy improves, the recorded prevalence of the disease continues to shift upward.
Timeline
2010 served as the baseline year for calculating the prevalence increase in Australia.
2024 estimates indicate that 37,756 people in Australia are living with the condition.
September 22, 2026, marked the official publication and release of the study data.
Deeper Dive
This study expands on the framework provided by the MS International Federation's Atlas of MS to track long-term disease trends. The findings update the figures previously established by this global resource to reflect current diagnostic and population shifts.
The data suggests that earlier diagnosis is playing a major role in the rising prevalence, which may lead to more patients accessing treatment at earlier disease stages. Patients and families can anticipate ongoing adjustments to care standards as medical systems adapt to these larger patient cohorts.
The takeaway
The data underscores the importance of continued investment in neurological care and earlier screening protocols to accommodate the growing number of patients. Early intervention remains critical for managing the condition as life expectancy for those with MS continues to rise.
Further reading
Learn more about the latest research and global health initiatives in the Stroke section.
Source note: This article includes information reported by News.
Live Poll
Do you believe rising disease statistics more often reflect improved reporting than actual changes in health?
